Streetbeat News

CNBX

CNBX Pharmaceuticals Inc

http://www.cannabics.com/

CEO

Eyal Barad

Employees

Industry

Medicinal and Botanical Manufacturing

Open

0.01

Mkt cap

193K

Volume

11K

High

0.01

P/E Ratio

0.02

52-wk high

0.02

Low

0.01

Div yield

N/A

52-wk low

0.01

Marijuana stocks experienced significant movements on February 12, 2024, with Canopy Growth leading the gainers with a 2607.14% increase, while AusCann Group Holdings led the losers with a 44% decrease. Notable companies like Tilray Brands and Cronos Group also saw substantial declines.

Portfolio Pulse from Benzinga Insights

February 12, 2024 | 9:30 pm

Marijuana stocks experienced significant movement with ESCO Technologies, Global Hemp Group, and others among top gainers, while companies like Aurora Cannabis and OrganiGram Holdings were among the losers. The article highlights the dramatic changes in stock prices for various companies within the marijuana industry, indicating a volatile trading day.

Portfolio Pulse from Benzinga Insights

February 08, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on February 7, 2024, with ESCO Technologies leading the gainers with an unprecedented rise. The sector saw a mix of sharp increases and declines among various companies, indicating a volatile market environment for cannabis-related stocks.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 9:30 pm

The article provides a detailed list of cannabis stock gainers and losers for February 5, 2024, highlighting significant movements in the market. Notable gainers include Tony G Co-Investment and Maple Leaf Green World, with increases of 81.16% and 45.45% respectively. On the losing end, EVIO led with a 99% decrease. Major US-listed companies mentioned include Eastside Distilling, Neptune Wellness Solutions, Village Farms International, Scotts Miracle-Gro, GrowGeneration, Innovative Industrial Properties, Canopy Growth, Tilray Brands, and Urban-gro.

Portfolio Pulse from Benzinga Insights

February 05, 2024 | 9:30 pm

Marijuana stocks experienced significant movements on February 1, 2024, with notable gainers including EVIO, Australis Capital, and OrganiGram Holdings, among others. EVIO led with a 9900.00% increase. On the downside, Rhinomed, Khiron Life Sciences, and Item 9 Labs were among the top losers. This reflects a volatile day in the cannabis sector, impacting several US-listed companies such as OrganiGram Holdings (OGI), Psychemedics (PMD), Cronos Group (CRON), Tilray Brands (TLRY), Canopy Growth (CGC), Eastside Distilling (EAST), 22nd Century Group (XXII), Greenlane Holdings (GNLN), SNDL Inc. (SNDL), and Aurora Cannabis (ACB).

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 9:30 pm

The article lists the cannabis stocks that experienced significant gains and losses on January 31, 2024. Notable gainers include Rhinomed, GrowLife, and Elixinol Wellness with increases of 200%, 100%, and 69.3% respectively. On the losing side, MedMen Enterprises and EVIO both plummeted by 99%. The article also mentions several other cannabis-related companies with varying degrees of price changes.

Portfolio Pulse from Benzinga Insights

January 31, 2024 | 9:30 pm

The article reports on the significant price movements of various cannabis-related stocks on January 30, 2024. Notable gainers include MedMen Enterprises, EVIO, Corbus Pharmaceuticals, and others, with MedMen and EVIO both closing up 9900.00% at $0.0001. On the losing side, Rhinomed led the declines with a 73.54% drop. The article lists both gainers and losers with their respective percentage changes and closing prices.

Portfolio Pulse from Benzinga Insights

January 30, 2024 | 9:30 pm

The article reports on the significant price movements of various marijuana stocks on January 29, 2024. Notable gainers include CordovaCann, Blueberries Medical, and 1933 Industries, with increases of 26.53%, 26.14%, and 15.88% respectively. Psychemedics, 4Front Ventures, and Canopy Growth also saw gains. On the losing side, EVIO plummeted by 99%, while Global Hemp Group and Corbus Pharmaceuticals experienced significant drops of 45.30% and 34.93%. The article was generated by Benzinga's automated content engine and reviewed by an editor.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 9:30 pm

Cannabis stocks experienced significant volatility on January 26, 2024, with Corbus Pharmaceuticals leading the gainers with a 240.88% increase, while Blueberries Medical topped the losers with a 27.49% decline. Other notable movers included SOL Global Investments, C21 Investments, and OrganiGram Holdings with substantial gains, and 1933 Industries, Target Group, and Item 9 Labs with notable losses.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on January 24, 2024. Notable gainers included Global Hemp Group, Target Group, and Item 9 Labs, with increases of 68.40%, 47.06%, and 14.29% respectively. Trulieve Cannabis and MJ Holdings also saw gains over 11%. Corbus Pharmaceuticals and Neptune Wellness Solutions were among the NASDAQ-listed gainers. Conversely, MedMen Enterprises and EVIO suffered dramatic losses, closing down 99.99% and 98.00%. Other notable losers included Khiron Life Sciences and Cara Therapeutics. The article was generated by Benzinga's automated content engine and reviewed by an editor.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.